Efficacy and safety of ritlecitinib in Chinese patients with alopecia areata: A single-centre real-world study

Published: 17 February 2025| Version 1 | DOI: 10.17632/nfm87k6jm5.1
Contributors:
, Wang Qin

Description

Supplementary Figure of Efficacy and Safety of Ritlecitinib in Chinese Patients with Alopecia Areata: A Single-Center Real-World Study.

Files

Institutions

Huashan Hospital Fudan University

Categories

Hair Disorder

Licence